Fig. 2: Acute oral mucosities by treatment groups. | Nature Communications

Fig. 2: Acute oral mucosities by treatment groups.

From: Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial

Fig. 2

A Incidence of acute oral mucosities for 179 evaluable patients. The difference in incidence of grade 3 RTOM during CCRT between groups was statistically significant (P = 0.030, two-sided Fisher’s exact test). Statistical note: no adjustments for multiple comparisons were applied, as the analysis focused on pre-specified differences in grade 3 RTOM. B Cumulative rate of grade ≥3 mucositis during treatment in UTI group (89 patients, at 7 weeks 23 at risk), Control Group (90 patients, at 7 weeks 37 at risk). Source data are provided as a Source Data file. *: Significant difference between groups (two-sided Fisher’s exact test; P < 0.05). UTI Ulinastatin.

Back to article page